Differences in characteristics between first and breakthrough neutropenic fever after chemotherapy in patients with hematologic disease

Differences in characteristics between first and breakthrough neutropenic fever after chemotherapy in patients with hematologic disease

Objective: This study was conducted to compare the clinical and microbiological characteristics of first and breakthrough neutropenic fever in hematologic malignancy patients after chemotherapy. Methods: Breakthrough neutropenic fever was any episode of fever, not present initially, that developed e...

Full description

Bibliographic Details
Main Authors:	Eun Young Nam, Kyoung-Ho Song, Nak-Hyun Kim, Moonsuk Kim, Chung-Jong Kim, Jeong-Ok Lee, Pyoeng Gyun Choe, Wan Beom Park, Ji-Hwan Bang, Eu Suk Kim, Sang-Won Park, Hong Bin Kim, Soo-Mee Bang, Nam Joong Kim, Myoung-don Oh
Format:	Article
Language:	English
Published:	Elsevier 2016-03-01
Series:	International Journal of Infectious Diseases
Subjects:	Breakthrough infections Febrile neutropenia Hematologic malignancy
Online Access:	http://www.sciencedirect.com/science/article/pii/S1201971216000072

Similar Items

The Organisms Isolated During Febrile Neutropenic Episodes
by: Kürşat KAPTAN, et al.
Published: (1999-03-01)

The Evaluation of Febrile Neutropenic Episodes in Patients with Hematologic Malignancies
by: Kemalettin AYDIN, et al.
Published: (2007-06-01)

The Guidelines for Febril Neutropenic Patients: The Comparison of Guidelines of IDSA and ECIL
by: Bircan KAYAASLAN
Published: (2016-03-01)

Evaluation of Febrile Neutropenic Attacks
by: Nebahat DİKİCİ, et al.
Published: (2002-09-01)

Evaluation of febrile neutropenic patients hospitalized in a hematology clinic
by: Mücahit Görük, et al.
Published: (2015-12-01)

Risk factors for neutropenic fever in non-Hodgkin’s lymphoma patients with primary granulocyte colony-stimulating factor prophylaxis
by: Yu Ri Kim, et al.
Published: (2021-09-01)

Treatment of community-onset pneumonia in neutropenic cancer patients: β-lactam monotherapy versus combination antibiotic regimens
by: Hyeri Seok, et al.
Published: (2019-06-01)

Fiberoptic bronchoscopy in the diagnosis and therapeutic decision for respiratory infections in hematological febrile neutropenic patients
by: Luiza Bento, et al.
Published: (2014-06-01)

Fiberoptic bronchoscopy in the diagnosis and therapeutic decision for respiratory infections in hematological febrile neutropenic patients
by: Luiza Bento, et al.
Published: (2014-06-01)

Investigation of Febrile Neutropenic Cases and Risk Factors
by: Mehmet ÖZDEN, et al.
Published: (2013-12-01)

Case reports of invasive mucormycosis associated neutropenic enterocolitis in leukemic children: diagnostic and treatment challenges and review of literature
by: Ali Amanati, et al.
Published: (2021-12-01)

The Evaluation of Nasal Cultures in Patients with Hematological Malignancies During Febrile Neutropenic Episodes
by: Mehmet Uluğ, et al.
Published: (2012-12-01)

Low humoral and cellular immune responses early after breakthrough infection may contribute to severe COVID-19
by: Chan Mi Lee, et al.
Published: (2023-03-01)

Distribution of Bacteria Isolated from Febrile Neutropenic Cases and Their Antibiotic Susceptibilities
by: Serap GENÇER, et al.
Published: (2003-09-01)

Management of the febrile neutropenic patient in 2023
by: David-Valentin Mangaloiu, et al.
Published: (2023-03-01)

Secondary Infections in Febrile Neutropenia in Hematological Malignancies: More Than Another Febrile Neutropenic Episode
by: Aslıhan Demirel, et al.
Published: (2015-07-01)

Evaluation of Febrile Neutropenic Episodes of Childhood Malignancies
by: Ersin Töret, et al.
Published: (2019-03-01)

Punched out skin lesions in a neutropenic child: A clue to fusariosis
by: Nalla Anuraag Reddy, et al.
Published: (2023-09-01)

Comparison of the Efficacy of Beta-Lactam Monotherapy and Beta-Lactam and Amikacin Combination Therapy for the Empirical Treatment of Febrile Neutropenic Patients
by: Mustafa DOĞAN, et al.
Published: (2009-03-01)

A sequential exploratory study to develop and validate neutropenic nursing care bundle for neutropenic patients admitted in a tertiary care hospital, Uttarakhand
by: Nitesh Dahiya, et al.
Published: (2022-01-01)

Efficacy of an antimicrobial stewardship intervention for early adaptation of antibiotic therapy in high-risk neutropenic patients
by: Claire Durand, et al.
Published: (2024-01-01)

Frequency and Culture Sensitivity of Febrile Neutropenic Episodes in Paediatric Patients of Acute Lymphoblastic Leukemia on Chemotherapy
by: Saima Akhtar et al.,
Published: (2018-11-01)

Plasma levels of procalcitonin and eight additional inflammatory molecules in febrile neutropenic patients
by: Letícia Carvalho Neuenschwander, et al.
Published: (2011-01-01)

Utilization Evaluation of Antimicrobial Agents in Neutropenic Cancer Patients in a Teaching hospital: Urgent of Drug Utilization Evaluation Studies
by: Hadi Hamishehkar, et al.
Published: (2015-10-01)

Dissecting bloodstream infections in febrile neutropenic patients with hematological malignancies, a decade-long single center retrospective observational study (2009–2019)
by: Halima El Omri, et al.
Published: (2024-01-01)

Evaluating the cost-effectiveness of [18F]FDG-PET/CT for investigation of persistent or recurrent neutropenic fever in high-risk haematology patients
by: Michelle Tew, et al.
Published: (2023-12-01)

Evaluation of Febrile Neutropenia in Hematologic Malignancy Patients
by: Müge ASLAN, et al.
Published: (2014-12-01)

Candidemia in Febrile Neutropenic Patients; a Brief Report
by: Maysam Yousefi, et al.
Published: (2018-06-01)

Candidemia in Febrile Neutropenic Patients; a Brief Report
by: Maysam Yousefi, et al.
Published: (2018-02-01)

Microbiological profiles and prognostic factors of infection mortality in febrile neutropenic children with malignancy
by: Yuni Astria, et al.
Published: (2021-10-01)

Detection and Control of Biofilm Formation by Staphylococcus aureus from Febrile Neutropenic Patient
by: El-Nagdy AH, et al.
Published: (2020-09-01)

Febrile neutropenia management in pediatric onco-hematologic patients: a systematic review
by: Tatiane Bertella, et al.
Published: (2021-10-01)

Prevalence of blood stream infections and associated factors among febrile neutropenic cancer patients on chemotherapy at Ocean Road Cancer Institute, Tanzania
by: Lambert C. Safari, et al.
Published: (2023-09-01)

Blood culture and antimicrobial susceptibility pattern of bacteria and fungi isolated from febrile neutropenic patients treated with chemotherapy at Taleghani hospital, Tehran
by: Rozita Khodashahi, et al.
Published: (2019-05-01)

Food-borne bacteremic illnesses in febrile neutropenic children
by: Anselm Chi-wai Lee, et al.
Published: (2011-08-01)

Investigating the presence of fungal agents in febrile neutropenic patients using different microbiological, serological, and molecular methods
by: Ahu Sönmez, et al.
Published: (2015-07-01)

Neutropenic Fever in Lung Cancer: Clinical Aspects Related to Mortality and Antibiotic Failure
by: Inês RODRIGUES, et al.
Published: (2021-11-01)

Continuous Intravenous Administration of Granulocyte-Colony-Stimulating Factors—A Breakthrough in the Treatment of Cancer Patients with Febrile Neutropenia
by: Călin Căinap, et al.
Published: (2021-06-01)

Systematic Review of the Short-Term versus Long-Term Duration of Antibiotic Management for Neutropenic Fever in Patients with Cancer
by: Kazuhiro Ishikawa, et al.
Published: (2023-03-01)

Standart and Lipozomal Amphotericin B in Febrile Neutropenia with Hematological Malignancies
by: H. Şenol COŞKUN, et al.
Published: (1998-06-01)